Compare Baqsimi or Gvoke With IM Glucagon for Severe Hypoglycemia

November 2019

Baqsimi (bak-SEE-mee) and Gvoke (JEE-vohk) are new glucagon Rxs that will be game changers for treating severe hypoglycemia.

Quick response is key. Severe hypoglycemia causes confusion, seizures, and loss of consciousness...increasing risk of injury and death.

Baqsimi is INTRANASAL glucagon. It's a ready-to-use powder sprayed in one nostril...and is absorbed without inhaling.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Safety Put Concerns About Ranitidine and Drug Safety in Perspective
Heart Failure Don't Jump to an SGLT2 Inhibitor for Heart Failure
Medicare Avoid Pitfalls With Medicare Rxs for DME
Diabetes Temper Buzz About the First Oral GLP-1 Agonist, Rybelsus
Diabetes Compare Baqsimi or Gvoke With IM Glucagon for Severe Hypoglycemia
HIV & AIDS Know How Descovy and Truvada Stack Up for HIV Pre-Exposure Prophylaxis (PrEP)
Alcohol Be Ready to Answer the Question, "Is It Okay to Drink Alcohol With This Med?"
Pain Management Consider Acute Pain Management Options for Patients on Buprenorphine/Naloxone
Breast Cancer Weigh Pros and Cons of Meds for Primary Prevention of Breast Cancer
Dermatology Set Realistic Expectations for Patients Asking About Scar Treatments